Stelzer Laurie 4
4 · Spyre Therapeutics, Inc. · Filed May 16, 2024
Insider Transaction Report
Form 4
Stelzer Laurie
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-14+11,323→ 11,323 totalExercise: $39.29Exp: 2034-05-14→ Common Stock (11,323 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 11,323 shares of the Issuer's common stock, which will vest and become exercisable in 12 equal monthly installments following May 14, 2024 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.